HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression von Bethel, M. Angelyn, Diaz, Rafael, Castellana, Noelia, Bhattacharya, Indranil, Gerstein, Hertzel C., Lakshmanan, Mark C.

Volltext

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial von Tuttle, Katherine R, Lakshmanan, Mark C, Rayner, Brian, Busch, Robert S, Zimmermann, Alan G, Woodward, D Bradley, Botros, Fady T

Volltext

Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1) von WYSHAM, Carol, BLEVINS, Thomas, ARAKAKI, Richard, COLON, Gildred, GARCIA, Pedro, ATISSO, Charles, KUHSTOSS, Debra, LAKSHMANAN, Mark

Volltext

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND von Konig, Manige, Riddle, Matthew C, Colhoun, Helen M, Branch, Kelley R, Atisso, Charles M, Lakshmanan, Mark C, Mody, Reema, Raha, Sohini, Gerstein, Hertzel C

Volltext

Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double‐blind study of 102 postmenopausal women with distal radial fractures von Aspenberg, Per, Genant, Harry K, Johansson, Torsten, Nino, Antonio J, See, Kyoungah, Krohn, Kelly, García‐Hernández, Pedro A, Recknor, Christopher P, Einhorn, Thomas A, Dalsky, Gail P, Mitlak, Bruce H, Fierlinger, Anke, Lakshmanan, Mark C

Volltext

Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7) von Tuttle, Katherine R., Lakshmanan, Mark C., Rayner, Brian, Zimmermann, Alan G., Woodward, Brad, Botros, Fady T.

Volltext

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States von Boye, Kristina S., Riddle, Matthew C., Gerstein, Hertzel C., Mody, Reema, Garcia‐Perez, Luis‐Emilio, Karanikas, Chrisanthi A., Lage, Maureen J., Riesmeyer, Jeffrey S., Lakshmanan, Mark C.

Volltext

Clinical Outcomes by Albuminuria Status with Dulaglutide versus Insulin Glargine in Participants with Diabetes and CKD: AWARD-7 Exploratory Analysis von Tuttle, Katherine R, Rayner, Brian, Lakshmanan, Mark C, Kwan, Anita Y M, Konig, Manige, Shurzinske, Linda, Botros, Fady T

Volltext

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabet... von Gerstein, Hertzel C., Ramasundarahettige, Chinthanie, Avezum, Alvero, Basile, Jan, Conget, Ignacio, Cushman, William C., Dagenais, Gilles R., Franek, Edward, Lakshmanan, Mark, Lanas, Fernando, Leiter, Lawrence A., Pogosova, Nana, Probstfield, Jeffrey, Raubenheimer, Peter J., Riddle, Matthew, Shaw, Jonathan, Sheu, Wayne H.-H., Temelkova-Kurktschiev, Theodora, Turfanda, Ibrahim, Xavier, Denis

Volltext

GLP-1 receptor agonists, CKD, and eGFR trajectory – Authors' reply von Tuttle, Katherine R, Lakshmanan, Mark C, Rayner, Brian, Busch, Robert S, Zimmermann, Alan G, Woodward, D Bradley, Botros, Fady T

Volltext

Adverse Events Reported by Postmenopausal Women in Controlled Trials With Raloxifene von DAVIES, GRAHAM C., HUSTER, WILLIAM J., LU, YILI, PLOUFFE, LEO, LAKSHMANAN, MARK

Volltext

944-P: HbA1c Change Is Associated with Retinopathy Outcomes during GLP-1RA CVOT Follow-Up von BETHEL, ANGELYN, DIAZ, RAFAEL, CASTELLANA, NOELIA, GERSTEIN, HERTZEL C., LAKSHMANAN, MARK

Volltext

Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis von Gerstein, Hertzel C, Lee, Shun-Fu, Paré, Guillaume, Bethel, M Angelyn, Colhoun, Helen M, Hoover, Anastasia, Lakshmanan, Mark, Lin, Yanzhu, Pirro, Valentino, Qian, Hui-Rong, Ruotolo, Giacomo, Ryden, Lars, Wilson, Jonathan M, Duffin, Kevin L

Volltext

Abstract 15586: Burden of Cardiovascular or Fatal Outcomes in People With Type 2 Diabetes and Cardiovascular Risk Factors Treated With Dulaglutide a Post Hoc Analysis From the Rewi... von Dagenais, Gilles, Lakshmanan, Mark C, Dyal, Leanne, Atisso, Charles Messan, Colhoun, Helen, Ryden, Lars E, Gerstein, Hertzel C

Volltext

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial von Gerstein, Hertzel C, Hart, Robert, Colhoun, Helen M, Diaz, Rafael, Lakshmanan, Mark, Botros, Fady T, Probstfield, Jeffrey, Riddle, Matthew C, Rydén, Lars, Atisso, Charles Messan, Dyal, Leanne, Hall, Stephanie, Avezum, Alvaro, Basile, Jan, Conget, Ignacio, Cushman, William C, Hancu, Nicolae, Hanefeld, Markolf, Jansky, Petr, Keltai, Matyas, Lanas, Fernando, Leiter, Lawrence A, Lopez-Jaramillo, Patricio, Muñoz, Ernesto Germán Cardona, Pogosova, Nana, Raubenheimer, Peter J, Shaw, Jonathan E, Sheu, Wayne H-H, Temelkova-Kurktschiev, Theodora

Volltext

Carnitine Is a Naturally Occurring Inhibitor of Thyroid Hormone Nuclear Uptake von Benvenga, S, Lakshmanan, M, Trimarchi, F

Volltext

Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial von Branch, Kelley R.H., Dagenais, Gilles R., Avezum, Alvaro, Basile, Jan, Conget, Ignacio, Cushman, William C., Jansky, Petr, Lakshmanan, Mark, Lanas, Fernando, Leiter, Lawrence A., Pais, Prem, Pogosova, Nana, Raubenheimer, Peter J., Ryden, Lars, Shaw, Jonathan E., Sheu, Wayne H.H., Temelkova‐Kurktschiev, Theodora, Bethel, M. Angelyn, Gerstein, Hertzel C., Chinthanie, Ramasundarahettige, Probstfield, Jeffrey L.

Volltext

Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin von Ferrannini, Giulia, Gerstein, Hertzel, Colhoun, Helen Martina, Dagenais, Gilles R, Diaz, Rafael, Dyal, Leanne, Lakshmanan, Mark, Mellbin, Linda, Probstfield, Jeffrey, Riddle, Matthew Casey, Shaw, Jonathan Edward, Avezum, Alvaro, Basile, Jan Neil, Cushman, William C, Jansky, Petr, Keltai, Mátyás, Lanas, Fernando, Leiter, Lawrence Alan, Lopez-Jaramillo, Patricio, Pais, Prem, Pīrāgs, Valdis, Pogosova, Nana, Raubenheimer, Peter Johann, Sheu, Wayne Huey-Herng, Rydén, Lars

Volltext

725-P: Protein Biomarkers Associated with Dulaglutide and Cardiovascular Events in REWIND von WILSON, JONATHAN M., PARE, GUILLAUME, LEE, SHUN FU, COLHOUN, HELEN M., QIAN, HUI-RONG, PIRRO, VALENTINA, HOOVER, ANASTASIA, LAKSHMANAN, MARK, RUOTOLO, GIACOMO, DUFFIN, KEVIN L., GERSTEIN, HERTZEL C.

Volltext

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial von Riddle, Matthew C, Gerstein, Hertzel C, Xavier, Denis, Cushman, William C, Leiter, Lawrence A, Raubenheimer, Peter J, Atisso, Charles M, Raha, Sohini, Varnado, Oralee J, Konig, Manige, Lakshmanan, Mark, Franek, Edward

Volltext